Monocyte count a potential biomarker for IPF prognosis, Australian registry data show
By Michael Woodhead
13 Feb 2020
Routinely measured blood cell tests could be used to stratify IPF patients by risk for poor outcomes and lung transplantation allocation, Australian research suggests. Increased monocyte count is a predictor of survival in patients with idiopathic pulmonary fibrosis, an analysis of data from the Australian IPF registry has shown. Respiratory physicians have confirmed US results ...